The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Abbvie; Horizant; Merrimack; Novartis; Prescient Therapeutics; Seagen; TapImmune Inc.; Tesaro
Phase Ib study of gedatolisib in combination with palbociclib and endocrine therapy (ET) in women with estrogen receptor (ER) positive (+) metastatic breast cancer (MBC) (B2151009).
 
Andres Forero-Torres
No Relationships to Disclose
 
Heather Han
No Relationships to Disclose
 
Elizabeth Claire Dees
Consulting or Advisory Role - Novartis (I)
Research Funding - Bayer; Cerulean Pharma; Genentech/Roche; Lilly; Merck; Novartis; Pfizer
 
Robert Wesolowski
Consulting or Advisory Role - Agenus; Novartis; Pfizer (Inst)
Research Funding - Acerta Pharma
Travel, Accommodations, Expenses - Agenus; Novartis; Pfizer
 
Aditya Bardia
Consulting or Advisory Role - bioTheranostics; Genentech; Novartis; Pfizer; Spectrum Pharmaceuticals
 
Peter Kabos
Consulting or Advisory Role - Lilly
Research Funding - Radius Health (Inst)
 
Rachel M. Layman
Research Funding - Novartis; Pfizer
 
Janice M. Lu
Honoraria - Novartis
 
Kenneth Alan Kern
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Rachelle Perea
Stock and Other Ownership Interests - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Kristen J. Pierce
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Brett Houk
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Nuzhat Pathan
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Hope S. Rugo
Honoraria - Genomic Health
Consulting or Advisory Role - Amgen
Speakers' Bureau - Genomic Health
Research Funding - Eisai (Inst); Genentech (Inst); GTx (Inst); Immunomedics (Inst); Incyte (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Mylan; Novartis; OBI Pharma; Pfizer; Puma Biotechnology; Roche/Genentech